Our mission is to build the leading AI-enabled biotech company, to reveal hidden biological mechanisms of disease and discover breakthrough drugs. By harnessing the power of causal AI, human multi-omics data, and our Gemini Digital Twins, we aim to accelerate the discovery of life-saving therapeutics to make a meaningful impact on the lives of patients.
Our AI approaches are poised to disrupt new areas of drug discovery, unlocking the potential to discover the next generation of breakthrough drugs by creating Gemini Digital Twins of human disease from multi-omic patient data.
Aitia’s pipeline of differentiated, novel programs prioritize neurodegenerative diseases to address the rapid, devastating impacts they have on patients and their families.
We are a world-class team of AI pioneers, R&D veterans, and biotech company builders backed by top-tier healthcare and strategic pharma leaders working toward our shared mission.
